ARCHIVES

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

This article is from The Cancer Letter archive.

Vol. 19 No. 16 | April 16, 1993

Download PDF Visit The Full Archive

Related Articles

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

In Congress: House Subcommittee Postpones FY2000 Markup; Porter Seeks 8% increase for NIH

July 23, 1999

Modeling: Like The Sims But No Graphics

November 26, 2010

Bristol-Myers Awards 42.5 Million In Cancer Grants

October 21, 1977

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014